PSTTF
Price:
$0.145
Market Cap:
$73.61M
Operating from Melbourne, Australia, Prescient Therapeutics Limited is a clinical-stage oncology company dedicated to pioneering novel pharmaceutical treatments for a variety of cancers. The company's primary investigational therapy, PTX-200, is currently undergoing several advanced clinical trials: a Phase 2a study for HER2-negative breast cancer, a Phase 1B/2 trial addressing relapsed and refractory acute myeloid leukemia (AML), and a Phase 1b trial for platinum-resistant ovarian cancer that has recurred or persisted. Another key pipeline asset is PTX-100, a RhoA inhibitor, engineered to combat both blood and solid tumors, particularly those characterized by specific Ras and RhoA genetic m...[Read more]
Industry
Biotechnology
IPO Date
2017-09-13
Stock Exchange
OTC
Ticker
PSTTF
According to Prescient Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -29.00. This represents a change of 796.41% compared to the average of -3.24 of the last 4 quarters.
The mean historical PE Ratio of Prescient Therapeutics Limited over the last ten years is -9.93. The current -29.00 PE Ratio has changed 29.10% with respect to the historical average. Over the past ten years (40 quarters), PSTTF's PE Ratio was at its highest in in the December 2012 quarter at 0.29. The PE Ratio was at its lowest in in the June 2021 quarter at -16.71.
Average
-9.93
Median
-5.62
Minimum
-36.13
Maximum
-2.51
Discovering the peaks and valleys of Prescient Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 463.54%
Maximum Annual PE Ratio = -2.51
Minimum Annual Increase = -72.35%
Minimum Annual PE Ratio = -36.13
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -4.84 | 23.66% |
| 2024 | -3.91 | -53.52% |
| 2023 | -8.41 | -57.13% |
| 2022 | -19.62 | -45.68% |
| 2021 | -36.13 | 463.54% |
| 2020 | -6.41 | 155.23% |
| 2019 | -2.51 | -72.35% |
| 2018 | -9.08 | 112.46% |
| 2017 | -4.28 | 3.70% |
| 2016 | -4.12 | 175.72% |
The current PE Ratio of Prescient Therapeutics Limited (PSTTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-5.72
5-year avg
-14.58
10-year avg
-9.93
Prescient Therapeutics Limited’s PE Ratio is less than Eupraxia Pharmaceuticals Inc. (-8.14), less than AnGes, Inc. (-3.59), less than Adocia S.A. (-5.06), less than Ascentage Pharma Group International (-8.95), less than Mind Cure Health Inc. (-4.70), less than Anteris Technologies Ltd (-3.84), greater than China Medical & HealthCare Group Limited (-35.11), greater than Leafly Holdings, Inc. (-41.14), less than Japan Medical Dynamic Marketing, Inc. (80.83), less than Cell MedX Corp. (-8.20),
| Company | PE Ratio | Market cap |
|---|---|---|
| -8.14 | $108.29M | |
| -3.59 | $142.50M | |
| -5.06 | $103.66M | |
| -8.95 | $127.31M | |
| -4.70 | $86.53M | |
| -3.84 | $120.50M | |
| -35.11 | $123.01M | |
| -41.14 | $114.90M | |
| 80.83 | $156.35M | |
| -8.20 | $126.33M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prescient Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Prescient Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Prescient Therapeutics Limited's PE Ratio?
How is the PE Ratio calculated for Prescient Therapeutics Limited (PSTTF)?
What is the highest PE Ratio for Prescient Therapeutics Limited (PSTTF)?
What is the 3-year average PE Ratio for Prescient Therapeutics Limited (PSTTF)?
What is the 5-year average PE Ratio for Prescient Therapeutics Limited (PSTTF)?
How does the current PE Ratio for Prescient Therapeutics Limited (PSTTF) compare to its historical average?